Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO)

Q1 2019 13F Holders as of 3/31/2019

Type / Class: Equity / Common Stock, $0.01 par value
Shares outstanding: 127M
Number of holders: 17
Total 13F shares, excl. options: 813K
Shares change: +813K
Total reported value, excl. options: $6.09M
Value change: +$6.09M
Number of buys: 16
Price: $7.50

Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q1 2019

17 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q1 2019.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 813K shares of 127M outstanding shares and own 0.64% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (242K shares), GEODE CAPITAL MANAGEMENT, LLC (134K shares), GOLDMAN SACHS GROUP INC (102K shares), BlackRock Inc. (68K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (63.3K shares), MILLENNIUM MANAGEMENT LLC (59.2K shares), Tibra Equities Europe Ltd (46.4K shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (26.9K shares), NORTHERN TRUST CORP (17.5K shares), and DEUTSCHE BANK AG\ (15K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.